'Mom and Pop' no more

Silva, Chris
January 2007
Employee Benefit News;Jan2007, Vol. 21 Issue 1, p30
The article focuses on the use of 1 Price Prescription program by independent pharmacies in the U.S. Developed by Dan Benamoz, chief executive officer (CEO) of Pharmacy Development Services (PDS), the program promotes the sale of a large list of generic drugs. Pharmacy owner Denise Weaver has been using the program for almost a year and has offered it to small companies. The program's benefits are also discussed.


Related Articles

  • Generics, The Purple Pill Saga And OTC's.  // Health & Stress;2003, Issue 2, p3 

    Focuses on the failure of generic drugs to reduce rising drug costs in the United States. Efforts by Astra-Zeneca to block generic versions of the best-selling prescription drug, Prilosec, after its patent expired in October 2001; Schering-Plough's offer of free seven-day trials to switch...

  • Coalition to educate consumers, address generic Rx legislation. Popolillo, Melissa C. // Drug Store News;7/20/98, Vol. 20 Issue 11, pCP1 

    Focuses on the formation of the Coalition for Affordable Pharmaceuticals in the United States. Goal of promoting legislation that will improve consumer access to affordable generic pharmaceutical products; Online forum for visitors to learn about generics; Challenges brought upon by branded...

  • New drugs, price hikes roil a resilient generics market. FREDERICK, JAMES // Drug Store News;2/15/99, Vol. 21 Issue 3, p63 

    Probes into the status of the generics market in the United States. Factors that drive generic substitutions; Comments from industry officials; Impact of consumers' demand.

  • Ontario generic pay cuts draw ire of Rx groups. Frederick, Jim // Drug Store News;5/17/2010, Vol. 32 Issue 6, p65 

    The article reports on the anger of pharmacy and generic drug advocates to the move of the Ontario Liberal government to cut generic prescription drug prices for patients covered by the Ontario Drug Benefit Program in half.

  • Generics in India and Europe evaluated.  // PharmacoEconomics & Outcomes News;11/3/2007, Issue 540, p13 

    The article focuses on a study which compared the prices of generic drugs in Europe and India. According to researchers, there may be potential for lessening prices of generic medicines in several countries. It cites that India had the lowest average unit price for eight of the medicines...

  • Savings of £2 billion expected from new Spanish law on generics.  // PharmacoEconomics & Outcomes News;8/6/2011, Issue 634, p11 

    The article reports that the Spanish government is expected to save about 2 billion euros annually following the introduction of mandatory generic prescribing.

  • Market share biggest influencer on generic pricing in EU.  // PharmacoEconomics & Outcomes News;10/1/2011, Issue 638, p2 

    The article reports on the findings of a market analysis conducted in Europe which showed that generic competition has had greatly impacted medicine prices in countries with a high generic market share than in countries with developing markets.

  • Discount drugs. Kritz, Francesca // Baby Talk;May2002, Vol. 67 Issue 4, p63 

    Provides tips on lowering prescription drug costs. Benefits from generic drugs; Online buying of drugs; Insurance coverage.

  • MPs say the market for generic drugs is `ripe for manipulation.'. Beecham, Linda // BMJ: British Medical Journal (International Edition);01/01/2000, Vol. 320 Issue 7226, p7 

    Criticizes the system for determining price of generic drugs in the United States. Views from medical practitioners; Information on the system; Details on the category of the system.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics